CYP19A1 and metabolic syndrome: Similarly, aromatase activity in SAT was associated with dyslipidemia in our cohort, as demonstrated by the positive association with fasting plasma triglycerides and negative association with plasma HDL-c concentrations (Padjusted < 0.05 and < 0.01 respectively).